Eritrea: Mai-Nefhi College of Engineering and Technology Graduates 383 Students
The degree program graduates include 13 in Agricultural Engineering, 26 in Chemical Engineering, 30 in Civil Engineering, 39 in Computer Science and Technology, 27 in Electrical and Electronics Technology, 27 in Mechanical Technology, and 28 in Mining Technology.
The diploma program graduates include 23 in Automotive Technology, 28 in Computer Application, 18 in Computer Technology and Networking, 13 in Construction Technology, 23 in Electrical Technology, 24 in Electronics Technology, 26 in Mining Technology, 11 in Surveying, and 11 in Cooling System Technology.
Dr. Araya Zeray, Dean of the College, stated that since its establishment in 2004, the College has been providing higher education in eight fields of study in degree programs and nine in diploma programs, significantly contributing to the production of professionals who play a vital role in the country's economic development.
Dr. Araya further noted that the College has 79 academic staff members—44 foreigners and 35 nationals. He also mentioned that as part of ongoing staff development efforts, 18 staff members are currently pursuing master's and PhD programs abroad in Russia, China, India, Hungary, and Japan.
A representative of the graduates, commending the support of parents, lecturers, and the college community, expressed their commitment to live up to the expectations of the Government and people who provided them with the opportunity for higher education.
The honorary guest, Mr. Abraha Asfaha, Minister of Public Works, underlined the significance of engineering and technology in national economic development and called on the graduates to apply their knowledge practically in their respective workplaces.
Since its establishment, Mai-Nefhi College of Engineering and Technology has graduated 7,671 students in degree and diploma programs.
Distributed by APO Group on behalf of Ministry of Information, Eritrea.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
7 hours ago
- Zawya
Africans' health challenges: The case for homegrown biomedical research
For decades, Africa has relied on foreign medical research and to tackle its health crises, and the results no doubt raises major concerns. From malaria to cancer, the continent continues to bear the highest burden of diseases that have long solutions elsewhere, or worse, diseases that remain neglected globally. Yet, the solution has always been within reach: Africa needs its own biomedical research revolution. The current model, where data, diagnostics, and drugs are imported, isn't just unsustainable, it creates a dependency that limits rapid responses to emerging threats and leaves local health systems perpetually unprepared. We will therefore consider some factors* The Price of Scientific Dependence: Consider this: when COVID-19 struck, African scientists were some of the last to access vaccine technology, clinical trial resources, and manufacturing capacity. The continent had to wait, negotiate, and sometimes beg for access to solutions. Meanwhile, region-specific diseases, such as Lassa fever, sickle cell disease, and schistosomiasis, remain under-researched because they are not considered global priorities. If Africa does not research its diseases, who will? This dependence not only delays responses but perpetuates inequity. It means millions die waiting for solutions that a robust, well-funded African biomedical research ecosystem could have delivered more quickly and affordably. Local science, local solutions: Homegrown biomedical research is about more than national pride. It ensures that health interventions are tailored to local genetics, environments, and socio-cultural contexts. For example, cancer drugs developed in Western labs may not account for unique genetic mutations prevalent among African populations, limiting their efficacy. By investing in local research, Africa can develop treatments tailored to its people, based on real-world data gathered from its diverse populations and ecosystems. It can create affordable diagnostics, accessible drugs, and policies grounded in science. Governments, the private sector, and regional bodies must step up their efforts. Investing in research is investing in the future: in pandemic preparedness, in reducing healthcare costs, and in creating a knowledge economy that can compete globally. A call to action: The African Union's ambition for health sovereignty can only be realized with strong biomedical research. Policymakers must embed research in national health strategies, universities must prioritize translational science, and private investors must see research as an opportunity, not a risk. Public health without biomedical research is essentially a matter of guesswork. And guesswork is not a strategy for a continent battling the double burden of infectious and non-communicable diseases. Science revolution for health equity: In conclusion, if Africa is to control its health destiny, it must lead in its scientific research. The time for dependency is over. A continent of over a billion people deserves more than hand-me-down science. It's time to fund our labs, empower our scientists, and generate the solutions we've always needed, because no one will understand our diseases better than we do. Copyright © 2022 Nigerian Tribune Provided by SyndiGate Media Inc. (
Zawya
9 hours ago
- Zawya
Regenerative farming takes root in South Africa as demand for sustainable exports grows
As global buyers tighten sustainability standards, South African farmers are starting to adopt regenerative farming practices at a growing pace — particularly those focused on export crops. Source: Freepik Regenerative farming works with natural processes to restore soil health, reduce chemical use, and increase resilience to climate shocks. The World Economic Forum reports that transitioning just 40% of global cropland to regenerative agriculture could cut 600 million tons of emissions — equivalent to the footprint of a small country. Arno Abeln, managing director at Agrimark, says the shift is gaining momentum in South Africa, though the pace varies by sector. "We're seeing major investment in these practices among wine, citrus and table grape producers, also in apple and pear production, because export markets are demanding it. It's less advanced in the grain sector, but we're starting to see more interest as producers explore ways to improve soil health over the long term," says Abeln. Export-facing crops lead the shift Abeln believes South Africa's lack of government farming subsidies means local producers have had to adapt faster and smarter. "South African farmers don't benefit from the government subsidies common in other countries. They've had to find innovative and efficient ways to farm to stay viable. Regenerative practices together with precision agriculture are playing a bigger role, especially as export markets adopt stricter sustainability standards." In the Swartland region, principles like crop rotation and integrated grazing have been used for years — helping maintain soil health naturally. "A farmer might plant 500 hectares of wheat one year, followed by canola the next, each crop nourishing the soil differently. After harvesting, sheep graze the fields, naturally fertilising the land. It's a holistic system — and a scientific one." Younger farmers driving mindset shift A generational shift is also driving the uptake of regenerative practices. "There's definitely a long-term view emerging – especially around soil health and resilience," says Abeln. "And with better soil health, you often see the potential for better yields and cost efficiencies too." International studies suggest input costs could drop by 25-50% over time for farmers who move away from synthetic fertilisers and pesticides. Data, not guesswork, key to long-term soil health Abeln says modern farming requires science-backed decisions, not habit-based practices. "Many farmers are still using the same fertiliser mix they relied on ten years ago. We help them move to smarter, insight-driven decisions that can improve yield and profitability." Agrimark, a national agricultural retailer, works with suppliers, plant diagnostics specialists and input providers to support this shift. "It's about replacing guesswork with data. When a farmer faces an issue, we don't just sell a product; we work with him on-site to understand the problem and coordinate the right expertise." "In some regions, like parts of the Northern Cape, soil degradation is a real risk. If we want to keep farming and feeding people, we have to prioritise soil health." All rights reserved. © 2022. Provided by SyndiGate Media Inc. (
Zawya
a day ago
- Zawya
Africa Centres for Disease Control and Prevention (Africa CDC) and European Commission Launch New Initiative to Strengthen Mpox Testing and Sequencing Across Africa
The Africa Centres for Disease Control and Prevention (Africa CDC) and the European Commission today announced the launch of the Partnership to Accelerate Mpox Testing and Sequencing in Africa (PAMTA), a landmark initiative to boost diagnostics and outbreak response capabilities in Mpox-affected African countries. Co-funded under the EU4Health 2024 Work Programme, PAMTA reflects the growing momentum of Africa–EU health cooperation and aims to reinforce the continent's resilience against current and future health threats. The initiative will accelerate testing, sequencing, capacity building, and local manufacturing efforts for mpox and other priority pathogens across Africa through a €9.4 million to Africa CDC and the African Society for Laboratory Medicine (ASLM), managed by the European Health and Digital Executive Agency (HaDEA). The project officially began on 1 June 2025 and will be implemented over three years. Africa CDC Director General, H.E. Dr Jean Kaseya, welcomed the initiative as a timely and strategic intervention to close the diagnostic gap for Mpox and other outbreaks in Africa. 'This partnership reflects our commitment to working with trusted partners to build agile and self-reliant public health systems across Africa. Together with the EU and our technical partners, we are setting a new benchmark for outbreak detection and response.' The PAMTA initiative focuses on four key objectives: scaling up Mpox testing with the goal of supporting over 150,000 tests across the continent; strengthening genomic sequencing capacity to track viral evolution and spread; building human resource capacity in molecular diagnostics, genomics, bioinformatics and data interpretation; and promoting the production and validation of locally developed testing kits within Africa. 'PAMTA marks a historic milestone as the first initiative jointly signed between the European Commission and Africa CDC,' said Deputy Head of DG HERA, Laurent Muschel. 'Building on HERA's earlier donation of Mpox vaccines, this action enables a critical next step: strengthening diagnostic capacities as part of a broader medical countermeasures approach. It reflects our shared commitment to reinforcing epidemic preparedness across Africa — from vaccines to diagnostics, from innovation to manufacturing. This action shows that, together, the African Union and the European Union can deliver tangible results to protect lives.' The launch of PAMTA builds on broader efforts by the EU and its partners to address the Mpox outbreak. By mid-2025, more than 600,000 vaccine doses had been delivered to African countries through HERA and Team Europe. Simultaneously, research initiatives such as MPX-RESPONSE and EDCTP3 continue to explore new therapeutic options, while the Africa Pathogen Genomics Initiative (PGI)—also funded through EU4Health—is enhancing public health laboratory networks and genomic surveillance across the continent through public private partnerships. PAMTA marks a significant milestone in EU–Africa collaboration for health resilience. By supporting comprehensive diagnostics and fostering local innovation, the initiative is helping to lay a strong foundation for Africa's long-term pandemic preparedness and response capabilities. Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
